Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Assembly Biosciences (ASMB) Change in Accured Expenses (2016 - 2026)

Assembly Biosciences has reported Change in Accured Expenses over the past 11 years, most recently at $1.2 million for Q4 2025.

  • For Q4 2025, Change in Accured Expenses rose 199.28% year-over-year to $1.2 million; the TTM value through Dec 2025 reached $114000.0, down 89.8%, while the annual FY2025 figure was $114000.0, 89.8% down from the prior year.
  • Change in Accured Expenses for Q4 2025 was $1.2 million at Assembly Biosciences, up from -$552000.0 in the prior quarter.
  • Over five years, Change in Accured Expenses peaked at $5.4 million in Q4 2021 and troughed at -$7.5 million in Q2 2021.
  • A 5-year average of -$79550.0 and a median of $444500.0 in 2024 define the central range for Change in Accured Expenses.
  • Biggest five-year swings in Change in Accured Expenses: crashed 2222.96% in 2023 and later skyrocketed 742.8% in 2025.
  • Year by year, Change in Accured Expenses stood at $5.4 million in 2021, then plummeted by 69.89% to $1.6 million in 2022, then decreased by 27.32% to $1.2 million in 2023, then plummeted by 65.02% to $417000.0 in 2024, then soared by 199.28% to $1.2 million in 2025.
  • Business Quant data shows Change in Accured Expenses for ASMB at $1.2 million in Q4 2025, -$552000.0 in Q3 2025, and $4.0 million in Q2 2025.